NURIX THERAPEUTICS INC

Insider trades by Nurix executives on 15 Oct 2026 show routine 10b‑5‑1 liquidity moves, not market signals—focus on fundamentals, pipeline, and shareholder alignment.

Nurix insider buys: Gregory Julia P. adds 22,583 shares at $23.67 as the stock rebounds from a 52‑week low, signaling renewed confidence in its biopharma pipeline and Roche partnership.